BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+19.77%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$1.14B
AUM Growth
+$1.14B
(+20%)
Cap. Flow
-$77.4M
Cap. Flow
% of AUM
-6.78%
Top 10 Holdings %
Top 10 Hldgs %
49.57%
Holding
80
New
10
Increased
28
Reduced
18
Closed
8
Top Buys
Top Sells
| 1 |
Dynavax Technologies
DVAX
|
$116M |
| 2 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$39.9M |
| 3 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$19.1M |
| 4 |
CEMP
Cempra, Inc.
CEMP
|
$15.8M |
| 5 |
IPXL
Impax Laboratories, Inc.
IPXL
|
$15.6M |
Sector Composition
| 1 | Healthcare | 83.88% |
| 2 | Consumer Discretionary | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $115M | 10% | 8,917,975 +3,829,092 | +75% | +$49.4M |
|
|
AVDL
2
Avadel Pharmaceuticals
AVDL
$1.43B
| $88.3M | 7.68% | 5,153,190 +147,577 | +3% | +$2.53M |
|
|
PGNX
3
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $67.7M | 5.88% | 8,951,169 | – | – |
|
4
Emergent Biosolutions
EBS
$443M
| $56.3M | 4.89% | 2,066,719 -13,800 | -0.7% | -$376K |
|
|
AEGR
5
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $53.4M | 4.64% | 2,548,863 +1,542,301 | +153% | +$32.3M |
|
6
AngioDynamics
ANGO
$417M
| $50.8M | 4.41% | 2,670,703 -304,524 | -10% | -$5.79M |
|
|
VOLC
7
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $44.6M | 3.88% | 2,494,854 +1,500,000 | +151% | +$26.8M |
|
8
Travere Therapeutics
TVTX
$1.56B
| $32.5M | 2.83% | 2,658,854 +100,000 | +4% | +$1.22M |
|
|
BDSI
9
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $28.8M | 2.5% | 2,396,399 +363,964 | +18% | +$4.37M |
|
|
PTX
10
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $28.6M | 2.49% | 3,050,000 -450,000 | -13% | -$4.23M |
|
11
Heron Therapeutics
HRTX
$207M
| $28.3M | 2.46% | 2,808,173 | – | – |
|
12
Assertio
ASRT
$80.4M
| $27.6M | 2.4% | 1,713,702 -600,000 | -26% | -$9.67M |
|
13
Amphastar Pharmaceuticals
AMPH
$1.42B
| $24.7M | 2.15% | 2,127,854 +150,000 | +8% | +$1.74M |
|
|
AMAG
14
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $24.4M | 2.13% | 573,530 -937,245 | -62% | -$39.9M |
|
|
PETX
15
DELISTED
Aratana Therapeutics, Inc.
PETX
| $22.4M | 1.95% | 1,259,471 -182,964 | -13% | -$3.26M |
|
|
LJPC
16
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $20.7M | 1.8% | 1,121,370 +14,324 | +1% | +$264K |
|
|
KND
17
DELISTED
Kindred Healthcare
KND
| $20.2M | 1.76% | 1,110,300 +615,000 | +124% | +$11.2M |
|
18
Rigel Pharmaceuticals
RIGL
$697M
| $19.3M | 1.68% | 8,501,750 +2,503,731 | +42% | +$5.68M |
|
|
DSCI
19
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $17.3M | 1.5% | 1,856,877 +32,500 | +2% | +$303K |
|
20
AtriCure
ATRC
$1.84B
| $16.5M | 1.43% | 825,902 -100,000 | -11% | -$2M |
|
|
ANAC
21
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $16.3M | 1.41% | 504,320 -276,500 | -35% | -$8.92M |
|
|
THOR
22
DELISTED
THORATEC CORPORATION
THOR
| $16.2M | 1.41% | 500,000 | – | – |
|
|
UAM
23
DELISTED
Universal American Corp
UAM
| $16.1M | 1.4% | 1,735,553 -144,806 | -8% | -$1.34M |
|
|
ACGN
24
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $15.5M | 1.35% | 3,525,700 | – | – |
|
|
25
Dynavax Technologies
DVAX
$1.19B
| $12.9M | 1.12% | 766,010 -6,894,090 | -90% | -$116M |
|